KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Gross Profit: 2011-2024

Historic Gross Profit for Pacira BioSciences (PCRX) over the last 14 years, with Dec 2024 value amounting to $530.5 million.

  • Pacira BioSciences' Gross Profit rose 11.97% to $145.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $567.5 million, marking a year-over-year increase of 9.82%. This contributed to the annual value of $530.5 million for FY2024, which is 8.20% up from last year.
  • Latest data reveals that Pacira BioSciences reported Gross Profit of $530.5 million as of FY2024, which was up 8.20% from $490.3 million recorded in FY2023.
  • In the past 5 years, Pacira BioSciences' Gross Profit registered a high of $530.5 million during FY2024, and its lowest value of $312.3 million during FY2020.
  • Over the past 3 years, Pacira BioSciences' median Gross Profit value was $490.3 million (recorded in 2023), while the average stood at $496.1 million.
  • In the last 5 years, Pacira BioSciences' Gross Profit decreased by 0.63% in 2020 and then increased by 28.48% in 2021.
  • Yearly analysis of 5 years shows Pacira BioSciences' Gross Profit stood at $312.3 million in 2020, then grew by 28.48% to $401.3 million in 2021, then climbed by 16.51% to $467.5 million in 2022, then rose by 4.87% to $490.3 million in 2023, then climbed by 8.20% to $530.5 million in 2024.